U.S. Physical Therapy, Inc. (USPH)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $1.49B
Last updated: Nov 17, 2026 at 11:05 AM ET
U.S. Physical Therapy, Inc. (USPH) P/E Ratio & Valuation History
U.S. Physical Therapy (USPH) trades at 37.2x trailing earnings and 1.8x sales. Its P/E of 37.2x is above its 5-year median of 33.1x. Its forward P/E is 32.9x. The median P/E across 8 similar companies is 22.8x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 13.1% higher over the next year. Its free cash flow yield is 4.6%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 37.2x |
| Forward P/E | 32.9x |
| Price to sales | 1.8x |
| Price to book | 3.5x |
| EV/EBITDA | 17.0x |
| Price to FCF | 21.5x |
| EV/FCF | 24.5x |
| PEG | 3.3 |
| FCF yield | 4.6% |
Historical Medians
Against its 10-year medians, its P/E is 2.5% above 36.3x, its P/S is 21.7% below 2.3x and its P/B is 16.7% below 4.2x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 37.2x | 33.1x | 36.3x |
| P/S | 1.8x | 2.0x | 2.3x |
| P/B | 3.5x | 2.9x | 4.2x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 29.8x in 2025 to 50.3x in 2020. 2025 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $78.09 | 29.8x | 1.5x | 2.5x |
| 2024 | $88.71 | 36.4x | 2.0x | 2.7x |
| 2023 | $93.14 | 36.4x | 2.2x | 2.9x |
| 2022 | $81.03 | 29.9x | 1.9x | 3.3x |
| 2021 | $95.55 | 30.1x | 2.5x | 4.2x |
| 2020 | $120.25 | 50.3x | 3.6x | 5.6x |
| 2019 | $114.35 | 40.5x | 3.0x | 6.1x |
| 2018 | $102.35 | 48.7x | 2.9x | 6.0x |
| 2017 | $72.20 | 35.4x | 2.1x | 4.4x |
| 2016 | $70.20 | 36.6x | 2.4x | 4.7x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About USPH
What is USPH's forward P/E ratio?
U.S. Physical Therapy has a forward P/E ratio of 32.9x.
Is USPH stock overvalued?
GNG's valuation label for USPH is Undervalued. Its P/E of 37.2x compares with a median of 22.8x across 8 similar companies.
What is USPH's price to sales ratio?
U.S. Physical Therapy has a price to sales ratio of 1.8x.
What is U.S. Physical Therapy's average P/E ratio over 5 years?
U.S. Physical Therapy's median P/E over the last 5 years is 33.1x, from 60 month-end values through Oct 2026.
What is USPH's PEG ratio?
U.S. Physical Therapy has a PEG ratio of 3.3.
USPH pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors